While smaller trials and systematic reviews indicate therapeutic potential, the quality of evidence is often low due to limited sample sizes, short study durations, and methodological inconsistencies. Large-scale, randomized controlled trials with long-term follow-up are urgently needed.
Cannabis bill increasing amount of weed users can buy in MA passes House – Worcester Telegram
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPatient AccessMassachusettsRegulationMedical Cannabis Why This MattersPurchase limit changes directly impact patient access to cannabis...
Understanding The Current Landscape | Recreational Marijuana Massachusetts Reopen
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical AccessRegulatory PolicyPatient CareSupply ChainMassachusetts Why This MattersMassachusetts recreational cannabis reopening patterns provide clinical...
Missouri Bill Pulling Hemp-Derived Cannabinoids Off Store Shelves Come November …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCSafetyIndustry Why This Matters Clinicians need to understand this regulatory shift because patients currently using...
Will hemp products be banned in 2026? Kentucky brand introduces new THC drinks
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Hemp ProductsThcRegulatory PolicyProduct SafetyPatient Access Why This MattersThe regulatory uncertainty around hemp-derived THC products...
Judge Denies SAM’s Temporary Restraining Order; CBD Pilot Program Launches
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdClinical ResearchRegulatory PolicyEvidence-Based MedicineLegal Framework Why This MattersCBD pilot programs represent controlled opportunities to...
High Tide Subsidiary NuLeaf Naturals Pursues Participation in US Medicare CBD Pilot Program
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MedicareCbdInsurance CoverageRegulatory PolicyAccess Why This MattersMedicare coverage for CBD would represent the first federal...
Bridging the Regulatory Chasm in Investigator‐Initiated Human Subject Cannabis Research
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research BarriersRegulatory PolicyEvidence-Based MedicineClinical PracticeFederal Scheduling Why This MattersRegulatory barriers continue to impede rigorous...
Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health.
The Dietary Supplement Health and Education Act of 1994 specified that dietary supplements must be swallowed. In this study, we investigated whether kratom-d…
Cannabis Cash Management: What Banks Wish Operators Understood – mg Magazine
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Regulatory PolicyPatient SafetySupply ChainBankingProduct Quality Why This MattersBanking restrictions force cannabis businesses into cash-heavy...